Copyright
©The Author(s) 2017.
World J Hepatol. Jul 18, 2017; 9(20): 884-895
Published online Jul 18, 2017. doi: 10.4254/wjh.v9.i20.884
Published online Jul 18, 2017. doi: 10.4254/wjh.v9.i20.884
Time between transplants (d) | 0-7 (n = 19) | 8-30 (n = 16) | > 30 (n = 86) | P value |
Age | 54 (18-67) | 44 (20-63) | 43 (19-70) | 0.086 |
Transplant MELD | 22 (10-40) | 17 (8-36) | 17 (6-31) | 0.104 |
CCI ≥ 1, n (%) | 10 (71) | 11 (61) | 44 (49) | 0.095 |
Indication, n (%) | ||||
Early graft dysfunction | 14 (74) | 2 (13) | 2 (2) | < 0.001 |
Graft rejection | 0 (0) | 1 (6) | 30 (35) | < 0.001 |
Vascular | 5 (26) | 13 (81) | 23 (27) | < 0.001 |
Disease recurrence | 0 (0) | 0 (0) | 24 (28) | 0.001 |
Other indications | 0 (0) | 0 (0) | 7 (8) | 0.106 |
- Citation: Al-Freah MAB, Moran C, Foxton MR, Agarwal K, Wendon JA, Heaton ND, Heneghan MA. Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation. World J Hepatol 2017; 9(20): 884-895
- URL: https://www.wjgnet.com/1948-5182/full/v9/i20/884.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i20.884